Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

Gammaherpesvirus infection and malignant disease in rhesus macaques experimentally infected with SIV or SHIV.

Marshall VA, Labo N, Hao XP, Holdridge B, Thompson M, Miley W, Brands C, Coalter V, Kiser R, Anver M, Golubeva Y, Warner A, Jaffe ES, Piatak M Jr, Wong SW, Ohlen C, MacAllister R, Smedley J, Deleage C, Del Prete GQ, Lifson JD, Estes JD, Whitby D.

PLoS Pathog. 2018 Jul 12;14(7):e1007130. doi: 10.1371/journal.ppat.1007130. eCollection 2018 Jul.

2.

Cancer Incidence in C3H Mice Protected from Lethal Total-Body Radiation after Amifostine.

Cook JA, Naz S, Anver MR, Sowers AL, Fabre K, Krishna MC, Mitchell JB.

Radiat Res. 2018 May;189(5):490-496. doi: 10.1667/RR14987.1. Epub 2018 Mar 12.

3.

Interleukin-27 Is a Potential Rescue Therapy for Acute Severe Colitis Through Interleukin-10-Dependent, T-Cell-Independent Attenuation of Colonic Mucosal Innate Immune Responses.

McLean MH, Andrews C, Hanson ML, Baseler WA, Anver MR, Senkevitch E, Staniszewska AK, Smith C, Davies LC, Hixon J, Li W, Shen W, Steidler L, Durum SK.

Inflamm Bowel Dis. 2017 Nov;23(11):1983-1995. doi: 10.1097/MIB.0000000000001274.

PMID:
29019857
4.

Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis.

Yang Y, Yang HH, Hu Y, Watson PH, Liu H, Geiger TR, Anver MR, Haines DC, Martin P, Green JE, Lee MP, Hunter KW, Wakefield LM.

Oncotarget. 2017 May 9;8(19):30621-30643. doi: 10.18632/oncotarget.15695.

5.

Adaptation of Laser Microdissection Technique for the Study of a Spontaneous Metastatic Mammary Carcinoma Mouse Model by NanoString Technologies.

Castro NP, Merchant AS, Saylor KL, Anver MR, Salomon DS, Golubeva YG.

PLoS One. 2016 Apr 14;11(4):e0153270. doi: 10.1371/journal.pone.0153270. eCollection 2016.

6.

Mass Spectrometry-Based Metabolomics Identifies Longitudinal Urinary Metabolite Profiles Predictive of Radiation-Induced Cancer.

Cook JA, Chandramouli GV, Anver MR, Sowers AL, Thetford A, Krausz KW, Gonzalez FJ, Mitchell JB, Patterson AD.

Cancer Res. 2016 Mar 15;76(6):1569-77. doi: 10.1158/0008-5472.CAN-15-2416. Epub 2016 Feb 15.

7.

PET/CT imaging of renal cell carcinoma with (18)F-VM4-037: a phase II pilot study.

Turkbey B, Lindenberg ML, Adler S, Kurdziel KA, McKinney YL, Weaver J, Vocke CD, Anver M, Bratslavsky G, Eclarinal P, Kwarteng G, Lin FI, Yaqub-Ogun N, Merino MJ, Linehan WM, Choyke PL, Metwalli AR.

Abdom Radiol (NY). 2016 Jan;41(1):109-18. doi: 10.1007/s00261-015-0599-1.

PMID:
26830617
8.

A dual role for Caspase8 and NF-κB interactions in regulating apoptosis and necroptosis of ovarian cancer, with correlation to patient survival.

Hernandez L, Kim MK, Noonan AM, Sagher E, Kohlhammer H, Wright G, Lyle LT, Steeg PS, Anver M, Bowtell DD; Australian Ovarian Cancer Study Group 57, Annunziata CM.

Cell Death Discov. 2015 Dec 14;1:15053. doi: 10.1038/cddiscovery.2015.53. eCollection 2015.

9.

Telomere dysfunction suppresses multiple endocrine neoplasia in mice.

Lee JH, Anver M, Kost-Alimova M, Protopopov A, DePinho RA, Rane SG.

Genes Cancer. 2014 Sep;5(9-10):306-19.

10.

A melanin-independent interaction between Mc1r and Met signaling pathways is required for HGF-dependent melanoma.

Wolnicka-Glubisz A, Strickland FM, Wielgus A, Anver M, Merlino G, De Fabo EC, Noonan FP.

Int J Cancer. 2015 Feb 15;136(4):752-60. doi: 10.1002/ijc.29050. Epub 2014 Jul 7.

11.

Combination of 13-Cis retinoic acid and lovastatin: marked antitumor potential in vivo in a pheochromocytoma allograft model in female athymic nude mice.

Nölting S, Giubellino A, Tayem Y, Young K, Lauseker M, Bullova P, Schovanek J, Anver M, Fliedner S, Korbonits M, Göke B, Vlotides G, Grossman A, Pacak K.

Endocrinology. 2014 Jul;155(7):2377-90. doi: 10.1210/en.2014-1027. Epub 2014 Apr 24.

12.

IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice.

Hodge DL, Berthet C, Coppola V, Kastenmüller W, Buschman MD, Schaughency PM, Shirota H, Scarzello AJ, Subleski JJ, Anver MR, Ortaldo JR, Lin F, Reynolds DA, Sanford ME, Kaldis P, Tessarollo L, Klinman DM, Young HA.

J Autoimmun. 2014 Sep;53:33-45. doi: 10.1016/j.jaut.2014.02.003. Epub 2014 Feb 28.

13.

Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma.

Simpson RM, Bastian BC, Michael HT, Webster JD, Prasad ML, Conway CM, Prieto VM, Gary JM, Goldschmidt MH, Esplin DG, Smedley RC, Piris A, Meuten DJ, Kiupel M, Lee CC, Ward JM, Dwyer JE, Davis BJ, Anver MR, Molinolo AA, Hoover SB, Rodriguez-Canales J, Hewitt SM.

Pigment Cell Melanoma Res. 2014 Jan;27(1):37-47. doi: 10.1111/pcmr.12185. Epub 2013 Nov 21.

14.

Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice.

Hanson ML, Hixon JA, Li W, Felber BK, Anver MR, Stewart CA, Janelsins BM, Datta SK, Shen W, McLean MH, Durum SK.

Gastroenterology. 2014 Jan;146(1):210-221.e13. doi: 10.1053/j.gastro.2013.09.060. Epub 2013 Oct 9.

15.

Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL-15Rα.

Chen J, Feigenbaum L, Awasthi P, Butcher DO, Anver MR, Golubeva YG, Bamford R, Zhang X, St Claire MB, Thomas CJ, Discepolo V, Jabri B, Waldmann TA.

Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13534-9. doi: 10.1073/pnas.1312911110. Epub 2013 Jul 31.

16.

Characterization of NADPH oxidase 5 expression in human tumors and tumor cell lines with a novel mouse monoclonal antibody.

Antony S, Wu Y, Hewitt SM, Anver MR, Butcher D, Jiang G, Meitzler JL, Liu H, Juhasz A, Lu J, Roy KK, Doroshow JH.

Free Radic Biol Med. 2013 Dec;65:497-508. doi: 10.1016/j.freeradbiomed.2013.07.005. Epub 2013 Jul 11.

17.

Selenium and selenoprotein deficiencies induce widespread pyogranuloma formation in mice, while high levels of dietary selenium decrease liver tumor size driven by TGFα.

Moustafa ME, Carlson BA, Anver MR, Bobe G, Zhong N, Ward JM, Perella CM, Hoffmann VJ, Rogers K, Combs GF Jr, Schweizer U, Merlino G, Gladyshev VN, Hatfield DL.

PLoS One. 2013;8(2):e57389. doi: 10.1371/journal.pone.0057389. Epub 2013 Feb 27.

18.

Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies.

Dave H, Anver MR, Butcher DO, Brown P, Khan J, Wayne AS, Baskar S, Rader C.

PLoS One. 2012;7(12):e52655. doi: 10.1371/journal.pone.0052655. Epub 2012 Dec 20.

19.

Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection.

Kurtz SL, Foreman O, Bosio CM, Anver MR, Elkins KL.

Infect Immun. 2013 Feb;81(2):585-97. doi: 10.1128/IAI.01249-12. Epub 2012 Dec 10.

20.

IKK-ε coordinates invasion and metastasis of ovarian cancer.

Hsu S, Kim M, Hernandez L, Grajales V, Noonan A, Anver M, Davidson B, Annunziata CM.

Cancer Res. 2012 Nov 1;72(21):5494-504. doi: 10.1158/0008-5472.CAN-11-3993. Epub 2012 Aug 31.

21.

The antioxidant tempol reduces carcinogenesis and enhances survival in mice when administered after nonlethal total body radiation.

Mitchell JB, Anver MR, Sowers AL, Rosenberg PS, Figueroa M, Thetford A, Krishna MC, Albert PS, Cook JA.

Cancer Res. 2012 Sep 15;72(18):4846-55. doi: 10.1158/0008-5472.CAN-12-1879. Epub 2012 Jul 17.

22.

Melanoma induction by ultraviolet A but not ultraviolet B radiation requires melanin pigment.

Noonan FP, Zaidi MR, Wolnicka-Glubisz A, Anver MR, Bahn J, Wielgus A, Cadet J, Douki T, Mouret S, Tucker MA, Popratiloff A, Merlino G, De Fabo EC.

Nat Commun. 2012 Jun 6;3:884. doi: 10.1038/ncomms1893.

23.

A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers.

Langan RC, Mullinax JE, Ray S, Raiji MT, Schaub N, Xin HW, Koizumi T, Steinberg SM, Anderson A, Wiegand G, Butcher D, Anver M, Bilchik AJ, Stojadinovic A, Rudloff U, Avital I.

J Cancer. 2012;3:231-40. doi: 10.7150/jca.4542. Epub 2012 Jun 1.

24.
25.

The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.

Balamurugan K, Wang JM, Tsai HH, Sharan S, Anver M, Leighty R, Sterneck E.

EMBO J. 2010 Dec 15;29(24):4106-17. doi: 10.1038/emboj.2010.280. Epub 2010 Nov 12.

26.

Sunscreen prevention of melanoma in man and mouse.

Klug HL, Tooze JA, Graff-Cherry C, Anver MR, Noonan FP, Fears TR, Tucker MA, De Fabo EC, Merlino G.

Pigment Cell Melanoma Res. 2010 Dec;23(6):835-7. doi: 10.1111/j.1755-148X.2010.00756.x. Epub 2010 Aug 20. No abstract available.

27.

Visualization and identification of IL-7 producing cells in reporter mice.

Mazzucchelli RI, Warming S, Lawrence SM, Ishii M, Abshari M, Washington AV, Feigenbaum L, Warner AC, Sims DJ, Li WQ, Hixon JA, Gray DH, Rich BE, Morrow M, Anver MR, Cherry J, Naf D, Sternberg LR, McVicar DW, Farr AG, Germain RN, Rogers K, Jenkins NA, Copeland NG, Durum SK.

PLoS One. 2009 Nov 10;4(11):e7637. doi: 10.1371/journal.pone.0007637.

28.

Proline oxidase functions as a mitochondrial tumor suppressor in human cancers.

Liu Y, Borchert GL, Donald SP, Diwan BA, Anver M, Phang JM.

Cancer Res. 2009 Aug 15;69(16):6414-22. doi: 10.1158/0008-5472.CAN-09-1223. Epub 2009 Aug 4.

29.

GalNAcalpha1-3Gal, a new prognostic marker for cervical cancer.

Li Q, Anver MR, Li Z, Butcher DO, Gildersleeve JC.

Int J Cancer. 2010 Jan 15;126(2):459-68. doi: 10.1002/ijc.24716.

30.

Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition.

Rapisarda A, Hollingshead M, Uranchimeg B, Bonomi CA, Borgel SD, Carter JP, Gehrs B, Raffeld M, Kinders RJ, Parchment R, Anver MR, Shoemaker RH, Melillo G.

Mol Cancer Ther. 2009 Jul;8(7):1867-77. doi: 10.1158/1535-7163.MCT-09-0274. Epub 2009 Jul 7.

31.

Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccines.

Li Q, Anver MR, Butcher DO, Gildersleeve JC.

Mol Cancer Ther. 2009 Apr;8(4):971-9. doi: 10.1158/1535-7163.MCT-08-0934.

32.

Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect.

Capitini CM, Herby S, Milliron M, Anver MR, Mackall CL, Fry TJ.

Blood. 2009 May 14;113(20):5002-9. doi: 10.1182/blood-2008-11-187385. Epub 2009 Mar 3.

33.

Smad ubiquitination regulatory factor 2 promotes metastasis of breast cancer cells by enhancing migration and invasiveness.

Jin C, Yang YA, Anver MR, Morris N, Wang X, Zhang YE.

Cancer Res. 2009 Feb 1;69(3):735-40. doi: 10.1158/0008-5472.CAN-08-1463. Epub 2009 Jan 20.

34.

Marked liver tumorigenesis by Helicobacter hepaticus requires perinatal exposure.

Diwan BA, Sipowicz M, Logsdon D, Gorelick P, Anver MR, Kasprzak KS, Anderson LM.

Environ Health Perspect. 2008 Oct;116(10):1352-6. doi: 10.1289/ehp.11493. Epub 2008 Jun 13.

35.

Strain-specific spontaneous and NNK-mediated tumorigenesis in Pten+/- mice.

Hollander MC, Balogh AR, Liwanag J, Han W, Linnoila RI, Anver MR, Dennis PA.

Neoplasia. 2008 Aug;10(8):866-72.

36.

The lamin B receptor under transcriptional control of C/EBPepsilon is required for morphological but not functional maturation of neutrophils.

Cohen TV, Klarmann KD, Sakchaisri K, Cooper JP, Kuhns D, Anver M, Johnson PF, Williams SC, Keller JR, Stewart CL.

Hum Mol Genet. 2008 Oct 1;17(19):2921-33. doi: 10.1093/hmg/ddn191. Epub 2008 Jul 11.

37.

Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis.

Calvo A, Catena R, Noble MS, Carbott D, Gil-Bazo I, Gonzalez-Moreno O, Huh JI, Sharp R, Qiu TH, Anver MR, Merlino G, Dickson RB, Johnson MD, Green JE.

Oncogene. 2008 Sep 11;27(40):5373-84. doi: 10.1038/onc.2008.155. Epub 2008 May 26.

38.

DNA hypomethylation caused by Lsh deletion promotes erythroleukemia development.

Fan T, Schmidtmann A, Xi S, Briones V, Zhu H, Suh HC, Gooya J, Keller JR, Xu H, Roayaei J, Anver M, Ruscetti S, Muegge K.

Epigenetics. 2008 May-Jun;3(3):134-42. Epub 2008 May 9.

39.

An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments.

Nam JS, Terabe M, Mamura M, Kang MJ, Chae H, Stuelten C, Kohn E, Tang B, Sabzevari H, Anver MR, Lawrence S, Danielpour D, Lonning S, Berzofsky JA, Wakefield LM.

Cancer Res. 2008 May 15;68(10):3835-43. doi: 10.1158/0008-5472.CAN-08-0215.

40.

Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1.

Wright MH, Robles AI, Herschkowitz JI, Hollingshead MG, Anver MR, Perou CM, Varticovski L.

Mol Cancer. 2008 Apr 7;7:29. doi: 10.1186/1476-4598-7-29.

41.

A model for obesity and gigantism due to disruption of the Ankrd26 gene.

Bera TK, Liu XF, Yamada M, Gavrilova O, Mezey E, Tessarollo L, Anver M, Hahn Y, Lee B, Pastan I.

Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):270-5. Epub 2007 Dec 27.

42.

Expression of POTE protein in human testis detected by novel monoclonal antibodies.

Ise T, Das S, Nagata S, Maeda H, Lee Y, Onda M, Anver MR, Bera TK, Pastan I.

Biochem Biophys Res Commun. 2008 Jan 25;365(4):603-8. Epub 2007 Nov 9.

43.

Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model.

Tang B, Yoo N, Vu M, Mamura M, Nam JS, Ooshima A, Du Z, Desprez PY, Anver MR, Michalowska AM, Shih J, Parks WT, Wakefield LM.

Cancer Res. 2007 Sep 15;67(18):8643-52.

44.

ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence.

Ha L, Ichikawa T, Anver M, Dickins R, Lowe S, Sharpless NE, Krimpenfort P, Depinho RA, Bennett DC, Sviderskaya EV, Merlino G.

Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):10968-73. Epub 2007 Jun 19.

45.

Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models.

Varticovski L, Hollingshead MG, Robles AI, Wu X, Cherry J, Munroe DJ, Lukes L, Anver MR, Carter JP, Borgel SD, Stotler H, Bonomi CA, Nunez NP, Hursting SD, Qiao W, Deng CX, Green JE, Hunter KW, Merlino G, Steeg PS, Wakefield LM, Barrett JC.

Clin Cancer Res. 2007 Apr 1;13(7):2168-77.

46.

Cellular and tissue distribution of intravenously administered agalsidase alfa.

Murray GJ, Anver MR, Kennedy MA, Quirk JM, Schiffmann R.

Mol Genet Metab. 2007 Mar;90(3):307-12. Epub 2006 Dec 22.

47.

Precancer in mice: animal models used to understand, prevent, and treat human precancers.

Cardiff RD, Anver MR, Boivin GP, Bosenberg MW, Maronpot RR, Molinolo AA, Nikitin AY, Rehg JE, Thomas GV, Russell RG, Ward JM.

Toxicol Pathol. 2006;34(6):699-707.

PMID:
17074738
48.

Absence of Y-chromosome sequences in tumors from African women with AIDS-related Kaposi sarcoma.

Mbulaiteye SM, Sternberg LR, Nsubuga MM, Anver MR, Mehta M, Biryahwaho B, Kambugu F, Rabkin CS, Biggar RJ.

Cancer Lett. 2007 Apr 18;248(2):229-33. Epub 2006 Aug 24.

PMID:
16934394
49.

Smad4 signalling in T cells is required for suppression of gastrointestinal cancer.

Kim BG, Li C, Qiao W, Mamura M, Kasprzak B, Anver M, Wolfraim L, Hong S, Mushinski E, Potter M, Kim SJ, Fu XY, Deng C, Letterio JJ.

Nature. 2006 Jun 22;441(7096):1015-9. Erratum in: Nature. 2006 Dec 7;444(7120):780. Kasperczak, Barbara [corrected to Kasprzak, Barbara].

PMID:
16791201
50.

Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation.

Nunez NP, Oh WJ, Rozenberg J, Perella C, Anver M, Barrett JC, Perkins SN, Berrigan D, Moitra J, Varticovski L, Hursting SD, Vinson C.

Cancer Res. 2006 May 15;66(10):5469-76.

Supplemental Content

Support Center